Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05865054 · ClinicalTrials.gov registry record

Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)

A clinical trial of Giant Cell Arteritis, sponsored by University of Pennsylvania.

Recruiting
Registry status
400
Enrollment target
4
Study locations

NCT05865054 is a study of Giant Cell Arteritis that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 400 participants, below the 993-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (60% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05865054, a study of Giant Cell Arteritis, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
400 participants
Enrollment target
4
Study locations

Study Summary

The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).

Conditions Studied

Giant Cell Arteritis

Interventions

  • DIAGNOSTIC_TEST Magnetic Resonance Imaging (MRI)

Study Locations (4)

Minnesota

  • Mayo Building and Gonda Building - Rochester

Pennsylvania

  • 3400 Civic Center Blvd - Philadelphia

Ontario

  • St. Joseph's Healthcare Hamilton - Hamilton

Würzburg

  • University Hospital Wuerzburg - Würzburg

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2020-07-29
Est. Completion 2033-07

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05865054

The ClinicalTrials.gov registry entry for NCT05865054 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 993-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (60% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Giant Cell Arteritis appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Imaging (MRI) is the first listed.

NCT05865054 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Minnesota, Pennsylvania, Ontario.

Frequently Asked Questions

What is clinical trial NCT05865054 about?

NCT05865054 is a clinical study titled "Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)". The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).

What is the current status of trial NCT05865054?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2020-07-29. Estimated completion is 2033-07.

What conditions does trial NCT05865054 study?

This clinical trial studies the following conditions: Giant Cell Arteritis.

What interventions are being tested in trial NCT05865054?

The interventions under investigation include: Magnetic Resonance Imaging (MRI) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05865054?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05865054 being conducted?

This trial has 4 study locations across Minnesota, Pennsylvania, Ontario, Würzburg. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Giant Cell Arteritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Giant Cell Arteritis

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.